Sanara MedTech Inc. SMTI
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 12.96% | 17.38% | 18.97% | 30.52% | 34.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.96% | 17.38% | 18.97% | 30.52% | 34.26% |
| Cost of Revenue | -4.49% | -5.88% | -7.60% | 2.82% | 7.73% |
| Gross Profit | 14.53% | 19.63% | 21.73% | 33.54% | 37.29% |
| SG&A Expenses | 8.88% | 5.98% | 6.47% | 12.58% | 18.64% |
| Depreciation & Amortization | -6.96% | -17.27% | -23.95% | -50.59% | -37.92% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.65% | 4.65% | 4.71% | 7.87% | 14.63% |
| Operating Income | 116.77% | 1,779.95% | 397.35% | 212.43% | 157.26% |
| Income Before Tax | 86.17% | 110.25% | 94.60% | 119.46% | 69.06% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 86.17% | 110.25% | 94.60% | 119.46% | 69.06% |
| Earnings from Discontinued Operations | -301.71% | -535.81% | -1,403.05% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -94.58% | -88.95% | -93.68% | -95.30% | -75.42% |
| Net Income | -222.15% | -193.82% | -288.66% | -348.29% | -51.36% |
| EBIT | 116.77% | 1,779.95% | 397.35% | 212.43% | 157.26% |
| EBITDA | 72.85% | 457.33% | 2,696.13% | 411.35% | 286.90% |
| EPS Basic | -219.19% | -189.91% | -282.11% | -339.97% | -49.09% |
| Normalized Basic EPS | 262.75% | 149.30% | 123.25% | 121.19% | 90.07% |
| EPS Diluted | -210.73% | -181.85% | -272.10% | -328.42% | -48.86% |
| Normalized Diluted EPS | 255.70% | 148.15% | 122.52% | 120.74% | 89.88% |
| Average Basic Shares Outstanding | 0.75% | 1.03% | 1.08% | 1.70% | 1.87% |
| Average Diluted Shares Outstanding | 1.49% | 3.63% | 2.87% | 3.50% | 2.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |